LN-078832
SDZ NVI-085 , 98% Min. , 104195-17-7
Update time: 2023-04-23
PRODUCT Properties
| Boiling point: | 417.6±45.0 °C(Predicted) |
| Density | 1.19±0.1 g/cm3(Predicted) |
| pka | 7.45±0.20(Predicted) |
Description and Uses
SDZ-NVI-085, also known as Naphtoxazine, is an α1 adrenergic receptor agonist potentially for the treatment of cognitive disorders and major depressive disorder. SDZ-NVI-085 behaves as a competitive antagonist of 5-hydroxytryptamine. SDZ-NVI-085 shifted 5-HT concentration-effect curves to the right, in a concentration-dependent manner, and Schild regression gave a pA2 estimate of 8.0.
